Prevalence and intensity of symptoms during outpatient chemotherapy in patients of a tertiary care unit.

Main Article Content

Daniela Rodríguez Cruz
Jesus Guatemala Pantoja
Eduardo Velázquez Moreno
Abigail Quintana Sánchez
Vianey Reyes García

Abstract

Introduction. Antineoplastic chemotherapy is one of the systemic cancer treatment modalities that is carried out through the administration of cytotoxic drugs, however, it causes symptoms during its administration. Objetive. To determine the prevalence and intensity of symptoms in patients who received outpatient chemotherapy treatment in a tertiary care unit. Methodology. Quantitative, cross-sectional, retrospective and analytical research. Carried out from March 1 to April 1, 2022 in the outpatient chemotherapy service of a tertiary care unit. Sample of 50 patients from 18 to 65 years of age without distinction of sex with a diagnosis of solid tumors. The instrument "Edmonton Symptom Assessment System (ESAS)" was used. Results. Exhaustion and difficulty sleeping are the main symptoms that occur during chemotherapy treatment, while the general feeling of malaise and shortness of breath occur as the least frequent. Regarding the intensity of the symptoms, exhaustion and difficulty sleeping are the symptoms that occur with greater intensity, compared to pain and shortness of breath, which are the symptoms with less intensity. By means of the complementary statistical analysis, differences in the intensity score of the symptoms between participants were determined. Conclusion. The prevalence and intensity of symptoms in patients undergoing chemotherapy treatment were identified.

Downloads

Download data is not yet available.

Article Details

How to Cite
Rodríguez Cruz, D. ., Guatemala Pantoja, J. ., Velázquez Moreno, E., Quintana Sánchez , A., & Reyes García , V. (2023). Prevalence and intensity of symptoms during outpatient chemotherapy in patients of a tertiary care unit. CuidArte Journal, 12(24). https://doi.org/10.22201/fesi.23958979e.2023.12.24.85532

References

Organización Mundial de la Salud. Día Mundial contra el Cáncer 2022: Por unos cuidados más justos. [Sitio en

Internet]. Disponible en: https://n9.cl/u4s8n

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer

Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020. Disponible en: https://gco.

iarc.fr/today.

Organización Panamericana de la Salud. Cáncer en las Américas. Oficina Regional para las Américas de la

Organización Mundial de la Salud. [Sitio en Internet].

INEGI. Estadísticas a propósito del día mundial contra el cáncer 2023. [Sitio de Internet]. Disponible en: https://n9.cl/

bw7d1

American Cancer Society. Cómo funcionan los medicamentos de quimioterapia 2019. [Sitio de Internet]. Disponible

en: https://bit.ly/3kX57o8

Instituto Nacional del Cáncer. Definición de quimioterapia. [Sitio de Internet]. [Consultado 3 marzo 2023].

Disponible en: https://bit.ly/3ysiDU1

Mejía-Rojas ME, Contreras-Rengifo A, Hernández-Carrillo M. Quality of life in women treated with chemotherapy for

breast cancer in Cali, Colombia. Biomedica. 2020; 40(2):349-361. doi: 10.7705/biomedica.4971.

Arias-Rojas M, Carreno MS, Sepulveda GA, Romero BI. Sobrecarga y calidad de vida de cuidadores de personas con

cáncer en cuidados. Rev Cuid. 2021; 12(2): e1248. doi.org/10.15649/cuidarte.1248

Carrillo-González GM. Los grupos de síntomas en personas con cáncer: una revisión integrativa. Aquichan. 2017;

(3):257-269. doi.org/10.5294/aqui.2017.17.3.3.

Rha SY, Lee J. Symptom clusters during palliative chemotherapy and their influence on functioning and quality of

life. Support Care Cancer. 2017 ;25(5):1519-1527. doi: 10.1007/s00520-016-3545-z.

Beesley VL, Ross LT, King TM, Campbell R, Nagle MR, Obermair A, Grant P, DeFazio A, Webb MP, Friedlander LP.

Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for

ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns). Gynecol Oncol. 2022;

(2):437-445. doi: 10.1016/j.ygyno.2021.12.006.

Cabezon GL, Custodio CS, Khosravi SP. Prevalencia y etiopatogenia del dolor oncológico neuropático en el anciano.

Revista española de Geriatría y Gerontología. 2016 51(3) 159-163. doi. 10.1016/j.regg.2015.07.008

Howell D, Husain A, Seow H, Liu Y, Kustra R, Atzema C, et al. Symptom clusters in a population-based ambulatory

cancer cohort validated using bootstrap methods. Eur J Cancer 2012; 48 (16):3073-81. doi. 0.1016/j.ejca.2012.04.008.

Contreras-Mollinedo N, Alvarado-Aguilar S, Molina-Solis R. Insomnio en el paciente oncológico. Gaceta Mexicana de

Oncología. 2013; (12)2: 101-107. doi. https://n9.cl/iqtnl

Hernández M, Cruzado JA, Prado C, Rodríguez E, Hernández C, González MA, Martin JC. Salud mental y malestar

emocional en pacientes con cáncer. Psicosociología; 2012; (9)2-3: 233-257. Disponible en: https://n9.cl/smzqe

Medline plus. Alta después de una quimioterapia. Biblioteca Nacional de Medicina. 2022 [Sitio de Internet].

Disponible en: https://n9.cl/mgpmc

Ayala de Calvo LE, Sepulveda-Carrillo GJ. Necesidades de cuidado de pacientes con cáncer en tratamiento

ambulatorio. Enferm. glob. 2017; 16(45): 353-383. doi.org/10.6018/eglobal.16.1.231681.

Sosa-Rosasa MP, Luna-Victoria FM. El cuidado de Enfermería en el cuerpo de la persona con cáncer. Enferm. Univ.

; 11(2):73-78. Disponible en: https://n9.cl/gp7w6

Osorio-Castaño JH, Vallejo-Mesa HY, Adarve-Gutierrez SE, Iglesias-Moré S, Osorio-Vargas JA. Cuidado con calidad

en quimioterapia ambulatoria. Diseño y validación del nuevo instrumento Care Quality Ambulatory. Aquichan. 2023;

(2):e2324. Disponible en: https://acortar.link/OBO8Cm

Capela A, Alonso R, Araújo A, Craveiro-Lopes B, Fragoso RM, Mansinho H, Moutinho R, Teixeira JA, Vieira C,

Veiga D. A Dor Neuropática Periférica Induzida por Quimioterapia no Doente Oncológico/Sobrevivente de Cancro

[Chemotherapy-Induced Peripheral Neuropathic Pain in Cancer Patients/Survivors]. Acta Med Port. 2023; 36(2):77-80.

doi: 10.20344/amp.18750.

Tantoy IY, Cataldo JK, Aouizerat BE, Dhruva A, Miaskowski C. A Review of the Literature on Multiple Co-Occurring

Symptoms in Patients with Colorectal Cancer Who Received Chemotherapy Alone or Chemotherapy With Targeted

Therapies. Cancer Nurs. 2016; 39(6): 437–445. doi: 10.1097/NCC.0000000000000343.

Hernández-Sampieri R, Mendoza C. Metodología de la investigación. Las rutas cuantitativa, cualitativa y mixta,

Ciudad de México, México: Editorial Mc Graw Hill Education, p. 335